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Abstract
Introduction: The aim of the study was to compare the advancement of thyroid cancer at diagnosis in Polish patients from the Silesian
district in the years 1999 and 2008.
Material and methods: The analyzed group consisted of Silesian district patients with thyroid cancer, who were registered by the Depart-
ment of Tumour Epidemiology of the Institute of Oncology in Gliwice in the years 1999 and 2008. From a group of 186 patients who
entered on record in 1999, 167 were qualified for this analysis. Similarly, from 238 patients registered in 2008, finally 226 were added. We
analyzed: sex, age at diagnosis, histotype of thyroid cancer, and DTC staging according to TNM (UICC 2002). In 1999 there were 137
females (82.04 %) and 30 males (17.93 %) with thyroid cancer diagnosed at ages 5–81 years. In 2008 there were 183 females (80.97%) and 43
males (19.03%) diagnosed at ages 14-80 years. In both groups, in 1999 and 2008, the median age was the same (51 years).
Results: In the year 1999, 119 (71%) and in 2008, 197 (87%) patients were diagnosed with papillary thyroid cancer (p = 0.0003). Relations
between age and sex were similar in these years. There was some increase in frequency of patients diagnosed with papillary microcancer
(pT1a), which was on the border of statistical significance (p = 0.05). A statistically significant increase of pT1 (p = 0.02) and decrease of pT4
(p = 0.001) and of pTx (p = 0.002) was observed in the year 2008 in the whole cohort of DTC patients.
Conclusions:
1. In 2008 the contribution of papillary histotype to all thyroid cancer patients (87%) was significantly higher than in 1999.
2. The percentage of DTC patients diagnosed with pT1 disease was significantly higher in 2008.
(Pol J Endocrinol 2010; 61 (5): 480–484)
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Streszczenie
Wstęp: Celem pracy było porównanie zaawansowania raka tarczycy rozpoznanego w województwie śląskim w 1999 i 2008 roku.
Materiał i metody: Analizowano polskich chorych z województwa śląskiego, którzy w 1999 i 2008 roku zostali poprzez karty nowotworo-
we zgłoszeni do Zakładu Epidemiologii Nowotworów Instytutu Onkologii w Gliwicach z rozpoznaniem raka tarczycy. Ze zgłoszonych
w 1999 roku 186 chorych ostatecznie do badania włączono 167, a ze zgłoszonych w 2008 roku 238 chorych włączono 226. Analizowano:
płeć chorych, wiek zachorowania, typ nowotworu tarczycy oraz zaawansowanie zróżnicowanego raka tarczycy przez klasyfikację TNM
według UICC z 2002 roku. W 1999 roku zgłoszono 137 kobiet (82,04%) i 30 mężczyzn (17,93%) w wieku 5–81 lat, a w 2008 roku 183 kobiet
(80,97%) i 43 mężczyzn (19,03%) w wieku 14–80 lat. W obu grupach, w 1999 i 2008 roku mediana wieku była taka sama (51 lat).
Wyniki: W 1999 roku u 119 (71%) chorych rozpoznano raka brodawkowatego tarczycy, a w 2008 roku u 197 (87%) (p < 0,0003). Rozkład
wieku i płci były podobne. U chorych w 2008 w porównaniu z rokiem 1999 obserwowano wzrost rozpoznania mikroraka brodawkowate-
go tarczycy (pT1a) na granicy znamienności statystycznej (p = 0,05) oraz znamienny statystycznie wzrost raka o niskim zaawansowaniu
guza pierwotnego: pT1 (p = 0,02), a spadek pT4 (p = 0,001) i Tx (p = 0,002).
Wnioski:
1. Udział raka brodawkowatego tarczycy we wszystkich rakach w województwie śląskim był w 2008 roku znacząco wyższy niż w roku
1999 i wynosił 87%.
2. Stwierdzono znamienny statystycznie wzrost rozpoznań raka w stadium pT1, a spadek pT4 i Tx, co należy uznać za zjawisko korzystne.
(Endokrynol Pol 2010; 61 (5): 480–484)
Słowa kluczowe: zróżnicowany rak tarczycy, zaawansowanie, częstość
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Introduction
Differentiated thyroid cancers (DTC), papillary and fol-
licular thyroid cancers, constitute the commonest en-
docrine malignancy. Among other endocrine neoplasms
they are characterized by the most favourable progno-
sis. During recent years an increasing incidence of thy-
roid cancer has been observed [1–3].
The aim of the study was to compare the staging of
thyroid cancers at diagnosis in patients from the Sile-
sian district of Poland in the years 1999 and 2008.
Material and methods
The analyzed group consisted of Silesian district patients
with thyroid cancer, who were registered by the De-
partment of Tumour Epidemiology of the Institute of
Oncology in Gliwice in the years 1999 and 2008. From
the group of 186 patients who entered on record in 1999,
for 167 the full data were available for this analysis. Sim-
ilarly, from 238 patients registered in 2008, finally
226 were analyzed. In total 393 patients (93% register)
were examined.
The following factors were analyzed: sex, age at the
time of diagnosis, histotype of thyroid cancer, and DTC
staging according to TNM system (UICC 2002). Patients
diagnosed in 1999 were selected on the basis of archi-
val data. Diagnosis was based on the evaluation of two
independent pathologists, the second from the Insti-
tute of Oncology in Gliwice, and staging of the archival
patient data of the whole disease course.
Statistical analysis was based on the Pearson c2 test
with Yates’s correction.
Results
In 1999 there were 137 females (82.04%) and 30 males
(17.96%) with thyroid cancer. Age range at the time of
diagnosis was 5–81 years (mean: 50.8 ± 13.8). In
2008 there were 183 females (80.97%) and 43 males
(19.03%) with thyroid cancer diagnosed in the age range
14–80 years (mean: 50.1 ± 14.4). There were no signifi-
cant changes in age and sex distribution between both
cohorts. In both groups, in 1999 and 2008, the median
age was the same (51 years).
The comparison of histological diagnoses between
the years 1999 and 2008 is presented on Figure 1. In the
year 1999 there were 167 patients registered, of which
119 (71%) had papillary thyroid cancer (PTC). In year
2008 there were 226 patients registered, among them
197 (87%) with PTC. The increase was statistically signi-
ficant (p = 0.0003). There was some increase in frequen-
cy of patients diagnosed with papillary microcancer (ac-
cording to the WHO definition), which was on the bor-
derline of statistical significance (p = 0.05) (Table I).
Differentiated thyroid cancer staging was analyzed
according to the TNM system, initially with a focus on
the primary tumour (Fig. 2.). The percentage of pa-
tients diagnosed with pT1 disease was significantly
higher in 2008 — 57.14% v. 45.06% (Table I). A statisti-
cally significant decrease of pT4 and Tx patients was
observed in 2008.
Figure 1. A comparison of histopathological diagnoses of thyroid cancer between the years 1999 and 2008
Rycina 1. Rozkład rozpoznań histopatologicznych nowotworów tarczycy w 1999 i 2008 roku
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Table I. A comparison of initial stage cancer (primary tumour) in the years 1999 and 2008
Tabela I. Rozkład zaawansowania guza pierwotnego w 1999 i 2008 roku
pT1a all pT1 pT2-pT3 pT4 Tx Total
Number % Number % Number % Number % Number %
1999 24 14.81 73 45.06 48 29.63 12 7.41 29 17.9 162
2008 52 23.21 128 57.14 75 33.49 4 1.79 17 7.59 224
p 0.05 0.02 0.42 0.001 0.002
Figure 2. A comparison of DTC initial tumor stage between the years 1999 and 2008 (primary tumour assessed according to TNM
UICC 2002)
Rycina 2. Rozkład zaawansowania guza pierwotnego według klasyfikacji UICC z 2002 roku
Figure 3. A comparison of the presence of DTS lymph node metastases in the years 1999 and 2008
Rycina 3. Rozkład przerzutów do węzłów chłonnych w 1999 i 2008 roku
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Figure 4. A  comparison of the presence of DTC distant metastases at cancer diagnosis in the years 1999 and 2008
Rycina 4. Rozkład przerzutów odległych zróżnicowanych raków tarczycy w 1999 i 2008 roku
The presence of lymph node metastases in the years
1999 and 2008 was also compared and is presented in
Figure 3. The percentage of patients diagnosed with N0
disease was higher in 2008 than in 1999, but the differ-
ence was not statistically significant. However, the per-
centage of patients diagnosed with Nx disease was low-
er in 2008 than in 1999 (p = 0.03). No difference in the
incidence of N1 stage was observed.
The comparison of the presence of distant metastases
in the years 1999 and 2008 is presented in Figure 4. There
were less distant metastases diagnosed in 2009; how-
ever, the comparison of their frequency did not yield
a significant result, while, on the contrary, the compar-
ison of frequencies of M0 patients revealed a signifi-
cantly higher frequency — 88.8% in 2 008 v. 82.7% in
1999 (p = 0.03).
Discussion
The present study compares the distribution of thyroid
cancer histotypes and the initial staging of DTC patients
from Silesia (in southern Poland) diagnosed in 1999 and
in 2008. In the group of patients diagnosed in 2008 the
frequency of PTC (including microcarcinoma) was high-
er and the difference was statistically significant. The
numbers of cases with medullary and anaplastic cancer
in 1999 and 2008 were similar, while follicular thyroid
cancer showed diminished frequency (p = 0.0015).
However, in the opinion of some authors, these chang-
es may also be related to better diagnostics or to differ-
ences in histopathological evaluation [2–4].
The reasons for the observed rise of absolute and
relative papillary thyroid cancer incidence are discussed
worldwide [1–3]. The most probable explanation seems
to be increased awareness and diagnostic efficiency.
Detection of small thyroid focal lesions by sonography
and their efficient diagnosis by fine needle aspiration
biopsy may lead to the detection of some papillary thy-
roid cancers (and especially microcancers) which could
never progress to clinically overt disease or would be
diagnosed at a later age. The observed increase of pT1
cancers and the borderline significant increase of pT1a
papillary microcancers are confluent with this hypoth-
esis. The more frequent occurrence of N0 and M0 DTC
speaks also in favour of this hypothesis. On the other
hand, one has also to consider the increasing supply of
stable iodine in Poland by obligatory iodination of ta-
ble salt, introduced in 1997. Interestingly, the contribu-
tion of follicular thyroid cancer, a histotype believed to
be diagnosed in iodine deficient areas more frequently
[5–9] was more than two-times lower in 2008 (7%) than
in 1999 (17%) (p = 0.0015). This fact could speak in
favour of the influence of iodine supply on the frequen-
cy of different thyroid cancer histotypes. On the other
hand, the accuracy of histopathological diagnosis of
thyroid cancer histotypes is now much better and the
follicular variant of PTC is diagnosed instead of false
positive diagnosis of follicular cancer [10, 11].
The large analysis of the accuracy of histopatholog-
ical diagnosis of thyroid cancer performed in Poland
[10, 11] led us to the conclusion that in the past (some
ten years ago and more) only 1/3 of all follicular thyroid
cancers was diagnosed accurately. Thus, the observed
decrease of frequency of follicular thyroid cancer is
probably, at least in part, the result of changing patho-
logical criteria of diagnosis. It should be stressed that
all the histopathological diagnoses considered in this
study, both in 1999 and 2008, were confirmed by an in-
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dependent evaluation carried out at the Institute of
Oncology in Gliwice.
Conclusions
1. Although we did not perform a complete epidemi-
ology analysis, our results show the relative increase
of the participation of papillary thyroid cancer (87%)
among all thyroid cancers and suggest an increase
in their absolute number.
2. The percentage of differentiated thyroid cancer pa-
tients diagnosed with pT1 disease was significantly
higher in 2008 than in 1999.
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